An atypical teratoid rhabdoid tumor (TH03_0016_S01) and myoepithelial carcinoma (TH03_0113_S01) harbored loss of SMARCB1 (OMIM 601607) (INI1) through a frameshift mutation or protein loss of unknown mechanism detected by immunohistochemistry, respectively. This evidence concerns the gene SMARCB1 and malignant myoepithelioma.